Hadassah

Hadassah Launches New Center for Treating Pediatric Vascular Defects

Tuesday, Apr 30 2013

The Hadassah Medical Organization has opened a multidisciplinary facility to treat pediatric vascular defects—a first for Israel. Ten percent of infants are born with vascular defects in various areas of the body. Vascular defects can develop while the child is still in utero and resulting symptoms can appear either at birth or later on during a child's adolescent years.

For most of these children, the defect will disappear within seven years; however, some may be left with scarring or aesthetic damage. Although only one percent of children born with vascular deformities need treatment to correct the defects in main arteries and airways, in many cases, the condition is not diagnosed correctly, which can prove life-threatening.

Until now, infants and children were sent abroad for corrective surgery. With the opening of the new center at Hadassah, these children can receive the same quality of treatment in Israel, as specialists from plastic surgery, dermatology, laryngology, diagnostic radiology, angiography, and invasive radiology combine their talents to build a comprehensive treatment plan.

"Today, we have access to minimally invasive measures for effective treatment," relates Dr. Adam Farkas of Hadassah's Vascular and Interventional Radiology Unit. "Early detection is the key, because it allows children to grow and develop well, both physically and socially, and to avoid unnecessary pain and suffering."

One method of treatment closes off the problematic blood vessels via insertion of a catheter through the groin. The area is cauterized until the vein or artery has shrunk to the point of blocking blood flow to the area, thus eventually causing it to disappear. The other treatment method is sclerotherapy, which also shrinks the problematic blood vessel, but with an injection of a special solution.

Dr. Farkas, age 32, who was born and raised in New York, recently immigrated to Israel with his wife and four children. He has a special interest in venous diseases and vascular malformations, for which he underwent specialized training at Boston (MA) Children's Hospital, an affiliate of Harvard Medical School. He has since brought to Hadassah some of the cutting-edge therapies he learned at Harvard.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.

READ MORE ›
alt_text

Monday, Sep 19 2016

Hadassah Hospital Treats Terror Victims After Stabbing Attacks

This last week has brought a burst of terror attacks.

READ MORE ›
alt_text

Thursday, Sep 15 2016

“Stunning Results” Continue with Hadassah’s Stem Cell Treatment to Reverse MS

The Hadassah Medical Center is continuing to receive positive findings with its Phase II clinical trial using its unique stem cell approach to stop the progression and reversing the disabilities of multiple sclerosis.

READ MORE ›
alt_text

Thursday, Sep 15 2016

2012 Hadassah Stage-Four Melanoma Patient Thankfully Healthy

"Doctors in Florida who pronounced me ‘soon-dead’ can't believe that I'm healthy today,” said Hadassah melanoma patient Stewart Greenberg.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More